Bridgefront Capital’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,240	Closed	-$336K	–	616
2023 Q1	$336K	Buy	+8,240	New	+$336K	0.21%	184
2021 Q2	–	Sell	-4,445	Closed	-$312K	–	828
2021 Q1	$312K	Buy	+4,445	New	+$312K	0.1%	414